Since the early 1990s, the introduction of biologic disease-modifying antirheumatic drugs (b-DMARDs) in managing rheumatological diseases has revolutionised the course of inflammatory chronic arthritis, improving the quality of life, slowing the radiographic progression, avoiding disability, preserving workability, and reducing mortality [...].
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3390/jcm13237303 | DOI Listing |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11642580 | PMC |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!